LAUREN MICHINA: Open Payments
NPI 1427742709 · ALTOONA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,610 in 91 payments from 9 companies in 2025. Trend: 2023 $579 · 2024 $1,224 · 2025 $1,610
Food & beverage: $1,610
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $512 |
| Ardelyx, Inc. | 22 | $466 |
| Janssen Biotech, Inc. | 8 | $173 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $157 |
| Regeneron Healthcare Solutions, Inc. | 4 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $94 |
| Ipsen Biopharmaceuticals, Inc | 4 | $72 |
| Intercept Pharmaceuticals, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $14 |
Products named: IBSRELA, RINVOQ, TREMFYA, XIFAXAN, DUPIXENT, CREON, IQIRVO, LINZESS.
Industry payments across PA — which companies pay providers there.
